Abivax S.A. ABVX 深 滬
已收盤 09-19 16:00:00 美东时间
82.30
-1.010
-1.21%
華盛通- 最 高83.99
- 今 開83.52
- 成交量 59.25万股
- 最 低 81.28
- 昨 收 83.31
- 總市值 60.55亿
- 52周最高 92.91
- 市盈率 靜 --
- 換手率 0.81%
- 52周最低 4.77
- 委 比 18.64%
- 總股本 7357.47万
- 歷史最高 92.91
- 量 比 0.70
- 振 幅 3.25%
- 歷史最低 4.77
- 每 手 1
- 風險率 25.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅280.95%！HC Wainwright & Co.上调Immix Biopharma目标价至8美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从7美元升至8美元；Maxim Group：上调CNS Pharma评级至"买入"，目标价20美元
09-15 11:13
SA Asks: Which biotechs could be acquired by year's end?
The fourth quarter has historically been a busy time for the biopharma industry, with the sector generally seeing a significant uptick in M&A activity. We asked Seeking Alpha analysts Stephen Ayers ...
09-14 04:18
RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around...
09-12 20:24
Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
Abivax SA has been admitted to the CAC Mid 60 and SBF 120 indices following Euronext Paris's annual review, effective September 19, 2025. This inclusion enhances Abivax's visibility and is expected to broaden its investor base by making its shares more accessible to institutional investors and index-linked funds. The decision reflects confidence in the Company's strategic vision and its commitment to advancing innovative therapies for patients wi...
09-12 15:45
美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
Abivax SA Reports Financial Results and Strategic Advances
Abivax SA Sponsored ADR ( ($ABVX) ) has released its Q2 earnings. Here is a bre...
09-10 11:56
BTIG Reiterates Buy on Abivax, Maintains $112 Price Target
BTIG analyst Julian Harrison reiterates Abivax (NASDAQ:ABVX) with a Buy and maintains $112 price target.
09-09 19:15
Abivax jumps amid takeover speculation
Abivax (NASDAQ:ABVX) shares rose 6.9% in Paris amid takeover speculation. Abivax ADRs gained 6%. There's speculation that Abivax (NASDAQ:ABVX) has attracted takeover interest, according to traders, wh...
09-05 23:43
Abivax’s 580% surge hands biotech hedge funds a rare 2025 win
Hedge funds specializing in biotech finally caught a break this summer, courtesy of a little-watched French drug developer, The Wall Street Journal reported on Saturday. Paris-based Abivax (NASDAQ:ABV...
08-31 20:30
Abivax’s Promising Phase 2b Study on Obefazimod for Crohn’s Disease
Abivax SA (($GB:0RA9)) announced an update on their ongoing clinical study. Abi...
08-29 00:33
